Dateline: Mon, 06 Aug 2007
freeNewsArticles Story Summary: “RICHMOND, Texas – Aug. 6 (SEND2PRESS NEWSWIRE) — CYNACON /OCuSOFT(R) (OCuSOFT, Inc.) specializes in ophthalmic research, development and supply to ophthalmologists and optometrists. They are excited to announce a new and innovative prescription-only ALODOX(R) Convenience Kit for adjunctive eyelid therapy and hygiene.”
A R T I C L E:
RICHMOND, Texas – Aug. 6 (SEND2PRESS NEWSWIRE) — CYNACON/OCuSOFT(R) (OCuSOFT, Inc.) specializes in ophthalmic research, development and supply to ophthalmologists and optometrists. They are excited to announce a new and innovative prescription-only ALODOX(R) Convenience Kit for adjunctive eyelid therapy and hygiene.
The ALODOX(R) Convenience Kit contains ALODOX(R) (Doxycycline Hyclate 20 milligrams); OCuSOFT(R) Lid Scrub(TM) PLUS Extra Strength Pre-Moistened Pads; and OCuSOFT(R) Lid Scrub(TM) Original Foaming Eyelid Cleanser. This new and convenient combination therapy promises to significantly increase patient compliance while improving overall eyelid-hygiene therapy. OCuSOFT(R) Lid Scrub(TM) PLUS Extra Strength Pre-Moistened Pads is an extra strength eyelid cleanser that uses a low-level preservative and moisturizer blend, offering a wide range of anti-bacterial properties. It is perfect for moderate to severe eyelid conditions.
OCuSOFT(R) Lid Scrub(TM) Original Foaming Eyelid Cleanser is an instant foam liquid that generates pre-lathered foam immediately upon depressing the control-tip pump. The foam formula provides patients who are on a lid-hygiene regimen, with added convenience. It is economical and ideal for shower use.
So, why combine all three? Reports confirm that ALODOX(R) is prescribed much more often than minocycline, partly because it is a more potent collagenase inhibitor.
Therefore, the use of low-dose doxycycline hyclate has demonstrated effective enzyme modulation treatment of inflammatory disease. And, at such low levels – 50 milligrams or less – doxycycline reduces inflammation, yet still maintains maximum plasma drug concentrations below the anti-microbial threshold, resulting in fewer side effects.
“We are excited to be able to offer the ALODOX Convenience Kit for systemic inflammatory relief,” Patrick Witham, Executive Vice President, CYNACON/OCuSOFT(R), said. “While traditional doxycycline has been prescribed for years, new research suggests that low-dose doxycycline is just as effective, and without the added side effects such as gastritis and photosensitivity.”
Coupled with OCuSOFT(R) Lid Scrub(TM) products, the ALODOX(R) Convenience Kit has a mission that will lead to increased patient satisfaction and compliance.
CYNACON/OCuSOFT(R) (OCuSOFT, Inc.), founded in 1986, is a company dedicated to addressing clinical needs through well-researched and technological solutions. They are dedicated to optimizing the delivery and performance of ophthalmic pharmaceutical products while improving patient care, quality of life, and compliance.
For more information on the ALODOX(R) Convenience Kit, visit: www.alodox.com. To learn more about the company and find out about other available products, visit: www.ocusoft.com.
###
Copyright © 2007 by CYNACON / OCuSOFT (OCuSOFT, Inc.) and Send2Press® Newswire, a service of Neotrope® – all rights reserved. Information believed accurate but not guaranteed. Sourced on: freeNewsArticles.com.
• Story Title: Ophthalmic Research and Development Company Launches Adjunctive Eyelid Therapy and Hygiene Product
• REFERENCE KEYWORDS/TERMS: OCuSOFT Lid Scrub, , , ALODOX Convenience Kit, Drugs and Pharmaceuticals, , , .
IMPORTANT NOTICE: some content which is considered “old” or “archival” may reference an event which has already occurred; some content possibly considered “advertorial” may also reference a promotion or time-limited/sensitive offering, and in all of these instances certain material may no longer be valid. For notably stale content, you should directly contact the company/person mentioned in the text (CYNACON / OCuSOFT (OCuSOFT, Inc.)); this site cannot assist you with information about products/services mentioned in the news article, nor handle any complaints or other issues related to any person/company mentioned or promoted in the above text. Information believed accurate but not guaranteed as of original date of story [Mon, 06 Aug 2007 19:46:00 GMT].
USE THIS CONTENT FOR FREE: To use this content in your newspaper, broadcast outlet, news portal, blog/ezine or similar, free of cost, CLICK HERE to learn how.